Net Cash Provided by (Used in) Operating Activities |
104M |
USD |
-46.1% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-46.7M |
USD |
+37.6% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-102M |
USD |
-19.6% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
140M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
54.5M |
shares |
+0.54% |
Q3 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-44.3M |
USD |
-234% |
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
591M |
USD |
-14% |
Q3 2024 |
Q3 2024 |
Deferred Income Tax Expense (Benefit) |
2.91M |
USD |
-90% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q3 2024 |
Q3 2024 |
Additional Paid in Capital |
283M |
USD |
+2.7% |
Q3 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2024 |
Q3 2024 |
Depreciation, Depletion and Amortization |
140M |
USD |
+7.92% |
Q3 2024 |
Q3 2024 |
Interest Expense |
1.12M |
USD |
-84.9% |
Q1 2024 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |